Hughes TP - Search Results

1

BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features.

Cross NC, Daley GQ, Green AR, Hughes TP, Jamieson C, Manley P, Mughal T, Perrotti D, Radich J, Skoda R, Soverini S, Vainchenker W, Verstovsek S, Villeval JL, Goldman JM. Cross NC, et al. Among authors: hughes tp. Leukemia. 2008 Nov;22(11):1975-89. doi: 10.1038/leu.2008.231. Leukemia. 2008. PMID: 19002192 No abstract available.

2

Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning.

Cullis JO, Schwarer AP, Hughes TP, Hows JM, Franklin I, Morgenstern G, Goldman JM. Cullis JO, et al. Among authors: hughes tp. Br J Haematol. 1992 Jan;80(1):33-9. doi: 10.1111/j.1365-2141.1992.tb06397.x. Br J Haematol. 1992. PMID: 1536808

3

Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation.

Cullis JO, Jiang YZ, Schwarer AP, Hughes TP, Barrett AJ, Goldman JM. Cullis JO, et al. Among authors: hughes tp. Blood. 1992 Mar 1;79(5):1379-81. Blood. 1992. PMID: 1536963 Free article. No abstract available.

4

p53 in chronic myeloid leukemia cell lines.

Bi S, Hughes T, Bungey J, Chase A, de Fabritiis P, Goldman JM. Bi S, et al. Leukemia. 1992 Aug;6(8):839-42. Leukemia. 1992. PMID: 1640738

5

Persistence of BCR/ABL transcripts after BMT for CML detected by PCR reflects a high risk of relapse.

Hughes TP, O'Shea P, Morgan G, Martiat P, Goldman JM. Hughes TP, et al. Bone Marrow Transplant. 1991;7 Suppl 2:23. Bone Marrow Transplant. 1991. PMID: 1878700 No abstract available.

6

Improved results with PCR for chronic myeloid leukaemia.

Hughes T, Goldman JM. Hughes T, et al. Lancet. 1990 Sep 29;336(8718):812. doi: 10.1016/0140-6736(90)93275-t. Lancet. 1990. PMID: 1976169 Clinical Trial. No abstract available.

7

Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse.

Hughes TP, Morgan GJ, Martiat P, Goldman JM. Hughes TP, et al. Blood. 1991 Feb 15;77(4):874-8. Blood. 1991. PMID: 1993225 Free article.

8

Detection and significance of minimal residual disease in patients with leukaemia and lymphoma.

Goldman JM, Hughes T. Goldman JM, et al. Bone Marrow Transplant. 1991;7 Suppl 1:66-9. Bone Marrow Transplant. 1991. PMID: 2043891 Review. No abstract available.

9

Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors.

Mackinnon S, Hows JM, Goldman JM, Arthur CK, Hughes T, Apperley JF, Jones L, Batchelor JR, Brookes P, Catovsky D, et al. Mackinnon S, et al. Exp Hematol. 1990 Jun;18(5):421-5. Exp Hematol. 1990. PMID: 2338131

10

Biological importance of residual leukaemic cells after BMT for CML: does the polymerase chain reaction help?

Hughes TP, Goldman JM. Hughes TP, et al. Bone Marrow Transplant. 1990 Jan;5(1):3-6. Bone Marrow Transplant. 1990. PMID: 2404529 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters